324 related articles for article (PubMed ID: 38203811)
1. Lipid Metabolism Modulation during SARS-CoV-2 Infection: A Spotlight on Extracellular Vesicles and Therapeutic Prospects.
D'Avila H; Lima CNR; Rampinelli PG; Mateus LCO; Sousa Silva RV; Correa JR; Almeida PE
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203811
[TBL] [Abstract][Full Text] [Related]
2. Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19.
Motallebnezhad M; Omraninava M; Esmaeili Gouvarchin Ghaleh H; Jonaidi-Jafari N; Hazrati A; Malekpour K; Bagheri Y; Izadi M; Ahmadi M
Pathol Res Pract; 2023 Jan; 241():154280. PubMed ID: 36580795
[TBL] [Abstract][Full Text] [Related]
3. A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention.
Machhi J; Shahjin F; Das S; Patel M; Abdelmoaty MM; Cohen JD; Singh PA; Baldi A; Bajwa N; Kumar R; Vora LK; Patel TA; Oleynikov MD; Soni D; Yeapuri P; Mukadam I; Chakraborty R; Saksena CG; Herskovitz J; Hasan M; Oupicky D; Das S; Donnelly RF; Hettie KS; Chang L; Gendelman HE; Kevadiya BD
J Neuroimmune Pharmacol; 2021 Jun; 16(2):270-288. PubMed ID: 33544324
[TBL] [Abstract][Full Text] [Related]
4. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators.
Dias SSG; Soares VC; Ferreira AC; Sacramento CQ; Fintelman-Rodrigues N; Temerozo JR; Teixeira L; Nunes da Silva MA; Barreto E; Mattos M; de Freitas CS; Azevedo-Quintanilha IG; Manso PPA; Miranda MD; Siqueira MM; Hottz ED; Pão CRR; Bou-Habib DC; Barreto-Vieira DF; Bozza FA; Souza TML; Bozza PT
PLoS Pathog; 2020 Dec; 16(12):e1009127. PubMed ID: 33326472
[TBL] [Abstract][Full Text] [Related]
5. Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS-CoV-2.
Chen X; Li H; Song H; Wang J; Zhang X; Han P; Wang X
J Extracell Vesicles; 2022 Dec; 11(12):e12288. PubMed ID: 36450704
[TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling of single extracellular vesicles reveals colocalization of SARS-CoV-2 with a CD81/integrin-rich EV subpopulation in sputum from COVID-19 severe patients.
Sun R; Cai Y; Zhou Y; Bai G; Zhu A; Kong P; Sun J; Li Y; Liu Y; Liao W; Liu J; Cui N; Xiang J; Li B; Zhao J; Wu D; Ran P
Front Immunol; 2023; 14():1052141. PubMed ID: 37251406
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of extracellular vesicles in COVID-19, a double-edged sword?
Xia X; Yuan P; Liu Y; Wang Y; Cao W; Zheng JC
Immunology; 2021 Aug; 163(4):416-430. PubMed ID: 33742451
[TBL] [Abstract][Full Text] [Related]
8. Lipid-based therapies against SARS-CoV-2 infection.
Alketbi EH; Hamdy R; El-Kabalawy A; Juric V; Pignitter M; A Mosa K; Almehdi AM; El-Keblawy AA; Soliman SSM
Rev Med Virol; 2021 Sep; 31(5):1-13. PubMed ID: 34546604
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and Extracellular Vesicles: An Intriguing Interplay.
Pocsfalvi G; Mammadova R; Ramos Juarez AP; Bokka R; Trepiccione F; Capasso G
Kidney Blood Press Res; 2020; 45(5):661-670. PubMed ID: 32957112
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicles: The Invisible Heroes and Villains of COVID-19 Central Neuropathology.
Chang H; Chen E; Hu Y; Wu L; Deng L; Ye-Lehmann S; Mao X; Zhu T; Liu J; Chen C
Adv Sci (Weinh); 2024 Mar; 11(10):e2305554. PubMed ID: 38143270
[TBL] [Abstract][Full Text] [Related]
11. Protective role of engineered extracellular vesicles loaded quercetin nanoparticles as anti-viral therapy against SARS-CoV-2 infection: A prospective review.
Raghav A; Giri R; Agarwal S; Kala S; Jeong GB
Front Immunol; 2022; 13():1040027. PubMed ID: 36569877
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles in COVID-19 prognosis, treatment, and vaccination: an update.
Hernández-Díazcouder A; Díaz-Godínez C; Carrero JC
Appl Microbiol Biotechnol; 2023 Apr; 107(7-8):2131-2141. PubMed ID: 36917275
[TBL] [Abstract][Full Text] [Related]
13. Small Extracellular Vesicles and COVID19-Using the "Trojan Horse" to Tackle the Giant.
Borowiec BM; Angelova Volponi A; Mozdziak P; Kempisty B; Dyszkiewicz-Konwińska M
Cells; 2021 Dec; 10(12):. PubMed ID: 34943891
[TBL] [Abstract][Full Text] [Related]
14. Potential Therapeutic Effect of Micrornas in Extracellular Vesicles from Mesenchymal Stem Cells against SARS-CoV-2.
Park JH; Choi Y; Lim CW; Park JM; Yu SH; Kim Y; Han HJ; Kim CH; Song YS; Kim C; Yu SR; Oh EY; Lee SM; Moon J
Cells; 2021 Sep; 10(9):. PubMed ID: 34572043
[TBL] [Abstract][Full Text] [Related]
15. Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19.
Kumar S; Zhi K; Mukherji A; Gerth K
Viruses; 2020 Apr; 12(5):. PubMed ID: 32357553
[TBL] [Abstract][Full Text] [Related]
16. The interplay between lipid droplets and virus infection.
Qu Y; Wang W; Xiao MZX; Zheng Y; Liang Q
J Med Virol; 2023 Jul; 95(7):e28967. PubMed ID: 37496184
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Profile of Procoagulant Extracellular Vesicles Reflects Complement System Activation and Platelet Hyperreactivity of Patients with Severe COVID-19.
Moraes ECDS; Martins-Gonçalves R; da Silva LR; Mandacaru SC; Melo RM; Azevedo-Quintanilha I; Perales J; Bozza FA; Souza TML; Castro-Faria-Neto HC; Hottz ED; Bozza PT; Trugilho MRO
Front Cell Infect Microbiol; 2022; 12():926352. PubMed ID: 35937696
[TBL] [Abstract][Full Text] [Related]
18. The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target.
Abu-Farha M; Thanaraj TA; Qaddoumi MG; Hashem A; Abubaker J; Al-Mulla F
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429572
[TBL] [Abstract][Full Text] [Related]
19. The Role of Extracellular Vesicles in SARS-CoV-2-Induced Acute Kidney Injury: An Overview.
Bernal C; How-Volkman C; Spencer M; El-Shamy A; Mohieldin AM
Life (Basel); 2024 Jan; 14(2):. PubMed ID: 38398672
[TBL] [Abstract][Full Text] [Related]
20. The Role of Extracellular Vesicles in COVID-19 Pathology.
Tahyra ASC; Calado RT; Almeida F
Cells; 2022 Aug; 11(16):. PubMed ID: 36010572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
